Direxion Daily Pharmaceutical & Medical Bull 3X ETF
DThis fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.
$13.70−1.38 (−9.15%)
- 1.22%
- $16M
- +95.5%
- 0.40%
- 0.1M sh
- $15.49
- low $7.49high $24.15
The ETF.net PILL Grade
D
Score 26 out of 100
- 28 of 31
Score 26 of 100 falls in the D band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.F13 out of 100Rank 27 of 31Mission
Whether the fund did what it promised, tested against its stated mandate.Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.B56 out of 100Rank 12 of 30Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.D25 out of 100Rank 28 of 31Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.F22 out of 100Rank 29 of 31
Our read on PILL
DPharma with the volume knob at 3x. PILL aims for 300% of the daily move in an equal-weighted index of US drugmakers, a rare single-industry leveraged bet where a small-cap counts about as much as a giant. The daily reset makes it a short-horizon tool.
The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the S&P Pharmaceuticals Select Industry Index.
Why people hold it
- One of the few US funds offering 3x daily exposure to a single industry: it targets 300% of the daily move of the S&P Pharmaceuticals Select Industry Index, with the leverage reset every day.direxion.com
- The index is modified equal-weighted across the pharmaceutical names in the S&P Total Market Index, so its roughly 50 holdings give mid- and small-cap drugmakers real weight instead of burying them under the mega-caps.finance.yahoo.com
- Live since 2017 from Direxion, a house built around daily leveraged and inverse funds, so the plumbing has run through several drug-pricing and biotech cycles.direxion.com
Worth knowing
- At 1.22% a year it costs more than broad-index 3x peers like FAS (0.92%) and UDOW (0.95%). Leverage on a niche industry is priced accordingly.
- Hold past one day and the math shifts: returns follow the path, and choppy stretches can erode value even if pharma ends up where it started. Direxion states the fund should not be expected to deliver 3x the index's cumulative return beyond a day.direxion.com
- It is non-diversified and tied to one industry, and it does not trade with the depth of the headline broad-market 3x funds, so spreads and order type matter more on entry and exit.finance.yahoo.com
PILL Holdings
- Stocks
- 67
- 79%
- Spsiph Swap Asset Leg (Spsiphctl)
Sectors
- Health Care100.0%
Geography
- United States98.19%
- Ireland1.81%
PILL Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Not enough history yet.
PILL$19,551
Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | PILL |
|---|---|
| Year to date | +22.9% |
| 1 month | −16.5% |
| 3 months | −21.9% |
| 1 year | +95.5% |
| 3 years | +35.7% |
| 5 years | −2.2% |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | PILL |
|---|---|---|
| 2026 YTD | +22.9% | |
| 2025 | +75.1% | |
| 2024 | −7.3% | |
| 2023 | −12.1% | |
| 2022 | −43.2% | |
| 2021 | −37.3% | |
| 2020 | +0.3% |
PILL in the news
PILL Dividends
- 0.40%
- $0.06
- $0.00094 per share
- Quarterly
Distribution history
PILL Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
- 64.1%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.66
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −82.0%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.80
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
PILL Cost
1.22%
PILL1.22%
- The middle half of 3x Leveraged Long funds
- Median 0.98%
25 of the 30 3x Leveraged Long funds charge less.
Other funds in 3x Leveraged Long
- DKORUDirexion Daily MSCI South Korea Bull 3X ETFExpense ratio 1.32%1 year return +197.0%
- DTPORDirexion Daily Transportation Bull 3X ETFExpense ratio 1.12%1 year return +27.8%
- DUMDDProShares - UltraPro MidCap 400Expense ratio 1.40%1 year return +36.1%
- DYINNDirexion Daily FTSE China Bull 3X SharesExpense ratio 1.34%1 year return −40.6%
- FMEXXDirexion Daily MSCI Mexico Bull 3X ETFExpense ratio 1.26%1 year return +26.6%